HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monika McClellan Selected Research

N- (4- glucuronyl- 3- nitrobenzyloxycarbonyl)doxorubicin

4/2002Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monika McClellan Research Topics

Disease

2Neoplasms (Cancer)
04/2006 - 04/2002
1Breast Neoplasms (Breast Cancer)
04/2006

Drug/Important Bio-Agent (IBA)

1AntibodiesIBA
04/2006
1DNA (Deoxyribonucleic Acid)IBA
04/2006
1Pharmaceutical PreparationsIBA
04/2006
1Coloring Agents (Dyes)IBA
04/2006
1Paclitaxel (Taxol)FDA LinkGeneric
04/2006
1EnzymesIBA
04/2002
1GlucuronidaseIBA
04/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2002
1ProdrugsIBA
04/2002
1N- (4- glucuronyl- 3- nitrobenzyloxycarbonyl)doxorubicinIBA
04/2002